Rating Change
UBS analysts downgraded The Chemours Company (NYSE:CC) from Buy to Neutral on August 10, 2026.
downgradeNYSE:CC
The Chemours Company (CC) Downgraded to Neutral by UBS
UBS analysts downgraded The Chemours Company (NYSE:CC) from Buy to Neutral on August 10, 2026.
At publication ·
What changed
The Chemours Company (NYSE:CC) · downgrade
- Firm
- UBS
- Rating
- Buy to Neutral
- Price at event
- $14.59
- Market capitalization
- $2.0B
At a glance
Key takeaways
- UBS downgraded The Chemours Company from Buy to Neutral on August 10, 2026, though the article does not specify the reasoning behind this downgrade.
Market Context
The Chemours Company operates in the Basic Materials sector. The stock currently trades at $14.59 with a market capitalization of $2.0B. The stock has declined 3.2% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow UBS's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for The Chemours Company
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 10, 2026 | UBS | Neutral | N/A |
| Aug 06, 2026 | Truist Securities | Buy | N/A |
| Aug 06, 2026 | RBC Capital | Outperform | N/A |
| Jul 01, 2026 | Mizuho | Outperform | N/A |
| May 21, 2026 | JP Morgan | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View CC Stock Page
Frequently Asked Questions
What does the Neutral rating mean for CC?
A rating of Neutral from UBS reflects the analyst's outlook on The Chemours Company (NYSE:CC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CC forecast page.